The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

HALO FINANCIAL STATEMENTS

Halozyme Therapeutics Inc — balance sheet, income statement and cash flow trends

HALOHalozyme Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M1 B1.5 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue1.7 B $Gross Profit1.3 B $ · 78%Operating Income944.5 M $ · 57%Pre-tax Income583.3 M $ · 35%Net Income to Owners413.6 M $ · 25%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.7 B $+41.2%
Gross Profit1.3 B $+35.9%
Operating Income944.5 M $+38.4%
EBITDA681.7 M $-13.9%
Net Income to Owners413.6 M $-25.8%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets2.6 B
  • Equity143.5 M $6%
  • Current Liabilities344.4 M $13%
  • Long-term Liabilities2.1 B $81%

Key Figures

YoY change
Total Assets2.6 B $+25.5%
Total Liabilities2.4 B $+41.4%
Total Equity143.5 M $-56.9%
Cash & ST Investments231 M $-57.9%
Total Debt2.1 B $+42.2%
Net Debt2 B $+37.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0250 M500 M750 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0250 M500 M750 M818.6 M $Operating-605.7 M $Investing-110.8 M $Financing102.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow818.6 M $+49.4%
Capital Expenditures12.4 M $+74.7%
Free Cash Flow806.2 M $+49.1%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on HALO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.